acetylcysteine and Parkinsonian Disorders

acetylcysteine has been researched along with Parkinsonian Disorders in 28 studies

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (32.14)29.6817
2010's18 (64.29)24.3611
2020's1 (3.57)2.80

Authors

AuthorsStudies
Du, Y; Guan, Y; Hao, Y; Le, W; Li, Z; Song, Y; Wang, F; Yang, X1
Dexter, DT; Harrison, IF; Powell, NM1
Cuenca, L; Estrada, C; Fernández-Villalba, E; Gil-Martínez, AL; Herrero, MT; Sánchez, C1
Assous, M; Gubellini, P; Had-Aissouni, L; Kachidian, P; Kerkerian-Le-Goff, L; Melon, C; Nafia, I; Salin, P1
Bui, LC; Dairou, J; Lamouri, A; Leger, T; Mihoub, M; Richarme, G1
Czarnecka, A; Kamińska, K; Konieczny, J; Lenda, T; Nowak, P1
Hassanzadeh, K; Izadpanah, E; Khosrobakhsh, F; Moloudi, MR; Rahimmi, A1
Elson, JL; Pienaar, IS; Yates, A1
Anis, HK; Dexter, DT; Harrison, IF1
Angelatou, F; Antonopoulos, I; Botsakis, K; Georgiou, CD; Grintzalis, K; Margarity, M; Matsokis, NA; Panagopoulos, NT; Theodoritsi, S1
Czarnecka, A; Konieczny, J; Lenda, T1
Antkiewicz-Michaluk, L; Czarnecka, A; Kamińska, K; Konieczny, J; Lenda, T1
Dairou, J; Richarme, G1
Bentea, E; Churchill, MJ; Deneyer, L; Hood, RL; Massie, A; Meshul, CK; Moore, C; Verbruggen, L1
Hashimoto, T; Ibuki, T; Iwanaga, T; Kishibuchi, R; Kitagawa, H; Mizuguchi, H; Momota, H; Nishihara, S; Onaka, Y; Sado, M; Wada, D; Watanabe, TK; Yamasaki, Y1
Johansson, SM; Modo, MM; Vernon, AC1
Amit, T; Bar-Am, O; Prosolovich, K; Weinreb, O; Youdim, MB1
Ito, H; Matsui, H; Takahashi, R; Takeda, S; Taniguchi, Y1
Ahmad, I; Kumar, A; Kumar, V; Pandey, HP; Patel, DK; Shukla, S; Singh, BK; Singh, C; Srivastava, G1
Hintermann, S; Jankovic, J; Le, W; Li, X; Tuo, H; Xie, WJ; Zhang, Z1
Branton, RL; Brundin, P; Clarke, DJ; Karlsson, J; Love, RM1
Bisceglio, G; Farrer, MJ; Hulihan, M; Kachergus, J; Lincoln, S; Lockhart, PJ; Mash, DC; Wilkes, K1
Conn, KJ; Eisenhauer, PB; Fine, RE; Gao, W; Lan, MS; McKee, A; Ullman, MD; Wells, JM1
Le, W; Pan, T; Qu, S; Wang, X; Xie, W; Zhang, X1
Halliwell, B; Hyun, DH; Jenner, P; Lee, M1
Agarwal, V; Diwakar, L; Iyengar, S; Karunakaran, S; Ramakrishnan, S; Ravindranath, V; Saeed, U1
Hattori, N; Imai, Y; Inoue, H; Mizuno, Y; Soda, M; Takahashi, R1
Kudo, M; Shimoke, K1

Other Studies

28 other study(ies) available for acetylcysteine and Parkinsonian Disorders

ArticleYear
HDAC6-mediated Hsp90 deacetylation reduces aggregation and toxicity of the protein alpha-synuclein by regulating chaperone-mediated autophagy.
    Neurochemistry international, 2021, Volume: 149

    Topics: Acetylcysteine; alpha-Synuclein; Animals; Chaperone-Mediated Autophagy; Histone Deacetylase 6; HSP90 Heat-Shock Proteins; Humans; Male; Mice; Mice, Inbred C57BL; Parkinsonian Disorders; Protein Aggregates

2021
The histone deacetylase inhibitor nicotinamide exacerbates neurodegeneration in the lactacystin rat model of Parkinson's disease.
    Journal of neurochemistry, 2019, Volume: 148, Issue:1

    Topics: Acetylation; Acetylcysteine; Animals; Cell Death; Disease Models, Animal; Dopaminergic Neurons; Histone Deacetylase Inhibitors; Male; Nerve Degeneration; Niacinamide; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley

2019
Effect of NAC treatment and physical activity on neuroinflammation in subchronic Parkinsonism; is physical activity essential?
    Journal of neuroinflammation, 2018, Nov-26, Volume: 15, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetylcysteine; Analysis of Variance; Animals; Calcium-Binding Proteins; Disease Models, Animal; Encephalitis; Glial Fibrillary Acidic Protein; Imaging, Three-Dimensional; Male; Mice; Mice, Inbred C57BL; Microfilament Proteins; Microscopy, Confocal; Neuroprostanes; Parkinsonian Disorders; Physical Conditioning, Animal; S100 Calcium Binding Protein beta Subunit; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase

2018
Progressive Parkinsonism by acute dysfunction of excitatory amino acid transporters in the rat substantia nigra.
    Neurobiology of disease, 2014, Volume: 65

    Topics: Acetylcysteine; Action Potentials; Animals; Dicarboxylic Acids; Disease Models, Animal; Exploratory Behavior; Forelimb; Free Radical Scavengers; Functional Laterality; Glutamate Decarboxylase; Glutamate Plasma Membrane Transport Proteins; In Vitro Techniques; Male; Motor Activity; Neuroglia; Neurotransmitter Uptake Inhibitors; Parkinsonian Disorders; Pyrrolidines; Rats; Rats, Wistar; Substantia Nigra; Thiobarbituric Acid Reactive Substances; Tyrosine 3-Monooxygenase

2014
Parkinsonism-associated protein DJ-1/Park7 is a major protein deglycase that repairs methylglyoxal- and glyoxal-glycated cysteine, arginine, and lysine residues.
    The Journal of biological chemistry, 2015, Jan-16, Volume: 290, Issue:3

    Topics: Acetylcysteine; Albumins; Apoptosis; Arginine; Aspartate Aminotransferases; Catalysis; Cell Survival; Cysteine; Escherichia coli; Fructose-Bisphosphate Aldolase; Glucose; Glycolates; Glyoxal; Humans; Intracellular Signaling Peptides and Proteins; Lactates; Lysine; Mass Spectrometry; Oncogene Proteins; Oxidative Stress; Parkinsonian Disorders; Protein Deglycase DJ-1; Pyruvaldehyde

2015
Decreased behavioral response to intranigrally administered GABAA agonist muscimol in the lactacystin model of Parkinson's disease may result from partial lesion of nigral non-dopamine neurons: comparison to the classical neurotoxin 6-OHDA.
    Behavioural brain research, 2015, Apr-15, Volume: 283

    Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcysteine; Animals; Cell Count; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; GABA-A Receptor Agonists; Homovanillic Acid; Locomotion; Male; Muscimol; Neurons; Oxidopamine; Parkinson Disease; Parkinsonian Disorders; Rats, Wistar; Receptors, GABA-A; Substantia Nigra

2015
N-acetylcysteine prevents rotenone-induced Parkinson's disease in rat: An investigation into the interaction of parkin and Drp1 proteins.
    Brain research bulletin, 2015, Volume: 113

    Topics: Acetylcysteine; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Drug Interactions; Dynamins; Male; Oxidative Stress; Parkinsonian Disorders; Protein Binding; Random Allocation; Rats; Rats, Wistar; Rotarod Performance Test; Rotenone; Substantia Nigra; Ubiquitin-Protein Ligases

2015
Pedunculopontine cell loss and protein aggregation direct microglia activation in parkinsonian rats.
    Brain structure & function, 2016, Volume: 221, Issue:4

    Topics: Acetylcysteine; alpha-Synuclein; Animals; Cell Count; Choline O-Acetyltransferase; Cholinergic Neurons; Disease Models, Animal; Dopaminergic Neurons; Male; Microglia; Neurons; Parkinson Disease; Parkinsonian Disorders; Pars Compacta; Pedunculopontine Tegmental Nucleus; Protein Aggregation, Pathological; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase

2016
Associated degeneration of ventral tegmental area dopaminergic neurons in the rat nigrostriatal lactacystin model of parkinsonism and their neuroprotection by valproate.
    Neuroscience letters, 2016, Feb-12, Volume: 614

    Topics: Acetylcysteine; Animals; Dopaminergic Neurons; Male; Neuroprotective Agents; Parkinsonian Disorders; Proteasome Inhibitors; Rats, Sprague-Dawley; Substantia Nigra; Valproic Acid; Ventral Tegmental Area

2016
17β-Estradiol/N-acetylcysteine interaction enhances the neuroprotective effect on dopaminergic neurons in the weaver model of dopamine deficiency.
    Neuroscience, 2016, Apr-21, Volume: 320

    Topics: Acetylcysteine; Animals; Dopaminergic Neurons; Drug Synergism; Estradiol; Female; Immunohistochemistry; Male; Mice; Mice, Neurologic Mutants; Nerve Degeneration; Neuroprotective Agents; Parkinsonian Disorders

2016
Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats.
    Neuroscience, 2016, Jun-02, Volume: 324

    Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcysteine; Amphetamine; Animals; Benzazepines; Central Nervous System Agents; Corpus Striatum; Dopamine; Dopamine Antagonists; Functional Laterality; Glutamic Acid; Haloperidol; Homovanillic Acid; Male; Movement; Parkinsonian Disorders; Rats, Wistar; Receptors, Dopamine; Rotation; Substantia Nigra

2016
The significance of rotational behavior and sensitivity of striatal dopamine receptors in hemiparkinsonian rats: A comparative study of lactacystin and 6-OHDA.
    Neuroscience, 2017, 01-06, Volume: 340

    Topics: Acetylcysteine; Amphetamine; Animals; Apomorphine; Benzazepines; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Functional Laterality; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pars Compacta; Raclopride; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation

2017
Parkinsonism-associated protein DJ-1 is a bona fide deglycase.
    Biochemical and biophysical research communications, 2017, 01-29, Volume: 483, Issue:1

    Topics: Acetylcysteine; Artifacts; Culture Media; Cysteine; Escherichia coli; Glucose; Glycation End Products, Advanced; Glycosylation; Glyoxal; Humans; Intracellular Signaling Peptides and Proteins; Mutation; Oncogene Proteins; Parkinsonian Disorders; Protein Deglycase DJ-1; Pyruvaldehyde

2017
Plastic changes at corticostriatal synapses predict improved motor function in a partial lesion model of Parkinson's disease.
    Brain research bulletin, 2017, Volume: 130

    Topics: Acetylcysteine; Animals; Behavior, Animal; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; Male; Mice, Inbred C57BL; Motor Activity; Neural Pathways; Neuronal Plasticity; Parkinson Disease; Parkinsonian Disorders; Pars Compacta; Post-Synaptic Density; Rotarod Performance Test; Synapses

2017
Protective effect against Parkinson's disease-related insults through the activation of XBP1.
    Brain research, 2009, Feb-27, Volume: 1257

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Acetylcysteine; Animals; Cell Death; Cell Line; Cell Survival; Cysteine Proteinase Inhibitors; DNA-Binding Proteins; Dopamine; Endoplasmic Reticulum; Endoribonucleases; Humans; Leupeptins; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neurons; Parkinsonian Disorders; Protein Serine-Threonine Kinases; Regulatory Factor X Transcription Factors; RNA, Messenger; Signal Transduction; Stress, Physiological; Transcription Factors; X-Box Binding Protein 1

2009
Non-invasive evaluation of nigrostriatal neuropathology in a proteasome inhibitor rodent model of Parkinson's disease.
    BMC neuroscience, 2010, Jan-05, Volume: 11

    Topics: Acetylcysteine; alpha-Synuclein; Animals; Apomorphine; Corpus Striatum; Cysteine Proteinase Inhibitors; Disease Models, Animal; Dopamine; Dopamine Agonists; Iron; Magnetic Resonance Imaging; Male; Mesencephalon; Motor Activity; Neurons; Parkinsonian Disorders; Random Allocation; Rats; Rats, Sprague-Dawley; Substantia Nigra

2010
Does 1-(R)-aminoindan possess neuroprotective properties against experimental Parkinson's disease?
    Antioxidants & redox signaling, 2011, Mar-01, Volume: 14, Issue:5

    Topics: Acetylcysteine; Animals; Catalase; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Humans; Hydrogen Peroxide; Indans; Male; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; PC12 Cells; Rats; Rats, Sprague-Dawley

2011
Ammonium chloride and tunicamycin are novel toxins for dopaminergic neurons and induce Parkinson's disease-like phenotypes in medaka fish.
    Journal of neurochemistry, 2010, Volume: 115, Issue:5

    Topics: Acetylcysteine; Ammonium Chloride; Animals; Disease Models, Animal; Dopamine; Nerve Tissue Proteins; Neurons; Neurotoxins; Oryzias; Parkinsonian Disorders; Phenotype; Substantia Nigra; Tunicamycin

2010
Involvement of NADPH oxidase and glutathione in zinc-induced dopaminergic neurodegeneration in rats: similarity with paraquat neurotoxicity.
    Brain research, 2012, Feb-15, Volume: 1438

    Topics: Acetophenones; Acetylcysteine; Animals; Apoptosis; Caspases; CD11b Antigen; Corpus Striatum; Cytochromes c; Dopamine; Dopaminergic Neurons; Enzyme Inhibitors; Glutathione; Male; Membrane Glycoproteins; Mitochondria; Motor Activity; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Paraquat; Parkinsonian Disorders; Phosphoproteins; Rats; Rats, Wistar; Serotonin; Substantia Nigra; Tyrosine 3-Monooxygenase

2012
Anti-parkinsonian effects of Nurr1 activator in ubiquitin-proteasome system impairment induced animal model of Parkinson's disease.
    CNS & neurological disorders drug targets, 2012, Volume: 11, Issue:6

    Topics: Acetylcysteine; Animals; Cysteine Proteinase Inhibitors; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Mice; Mice, Inbred C57BL; Microglia; Motor Activity; Neostriatum; Nuclear Receptor Subfamily 4, Group A, Member 2; Parkinsonian Disorders; Proteasome Endopeptidase Complex; Real-Time Polymerase Chain Reaction; RNA, Messenger; Substantia Nigra; Transcriptional Activation; Vesicular Monoamine Transport Proteins

2012
Effects of antioxidant pretreatment on the survival of embryonic dopaminergic neurons in vitro and following grafting in an animal model of Parkinson's disease.
    Cell transplantation, 2002, Volume: 11, Issue:7

    Topics: Acetylcysteine; Animals; Antioxidants; Cells, Cultured; Chromans; Disease Models, Animal; Dopamine; Drug Combinations; Female; Fetus; Glutathione; Graft Survival; Male; Neurons; Oxidopamine; Parkinsonian Disorders; Piperazines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Stem Cell Transplantation; Stem Cells; Substantia Nigra

2002
DJ-1 mutations are a rare cause of recessively inherited early onset parkinsonism mediated by loss of protein function.
    Journal of medical genetics, 2004, Volume: 41, Issue:3

    Topics: Acetylcysteine; Adolescent; Adult; Age of Onset; Amino Acid Sequence; Animals; Cell Line; DNA Mutational Analysis; Female; Genes, Recessive; Humans; Intracellular Signaling Peptides and Proteins; Male; Middle Aged; Molecular Sequence Data; Mutation; Oncogene Proteins; Parkinsonian Disorders; Protein Deglycase DJ-1; RNA, Messenger

2004
Identification of the protein disulfide isomerase family member PDIp in experimental Parkinson's disease and Lewy body pathology.
    Brain research, 2004, Oct-01, Volume: 1022, Issue:1-2

    Topics: 1-Methyl-4-phenylpyridinium; Acetylcysteine; Aged; Aged, 80 and over; Analysis of Variance; Animals; Blotting, Northern; Blotting, Western; Cell Differentiation; Cell Line, Tumor; Dopamine; Female; Gene Expression Regulation; Humans; Immunohistochemistry; Lewy Bodies; Male; Middle Aged; Neuroblastoma; Nuclear Proteins; Parkinsonian Disorders; Postmortem Changes; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Tretinoin

2004
Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration.
    Biochemical and biophysical research communications, 2005, Jul-29, Volume: 333, Issue:2

    Topics: Acetylcysteine; Animals; Deferoxamine; Iron Chelating Agents; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neuroprotective Agents; Parkinsonian Disorders; Proteasome Inhibitors; Substantia Nigra; Treatment Outcome; Ubiquitin

2005
Effect of overexpression of wild-type or mutant parkin on the cellular response induced by toxic insults.
    Journal of neuroscience research, 2005, Oct-15, Volume: 82, Issue:2

    Topics: 1-Methyl-4-phenylpyridinium; Acetylcysteine; Aldehydes; Apoptosis; Cell Death; Cell Line, Tumor; Drug Resistance; Enzyme Inhibitors; Genetic Predisposition to Disease; Glutamic Acid; Guanine; Humans; Hydrogen Peroxide; Mutation; Nerve Degeneration; Neurons; Neurotoxins; Oxidative Stress; Parkinsonian Disorders; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Substantia Nigra; Tyrosine; Ubiquitin-Protein Ligases

2005
Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2007, Volume: 21, Issue:9

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetylcysteine; Alkynes; Animals; Antioxidants; Antiparkinson Agents; Biotransformation; Carrier Proteins; Cell Nucleus; Co-Repressor Proteins; Cystathionine gamma-Lyase; Cytosol; Dopamine; Drug Evaluation, Preclinical; Electron Transport Complex I; Enzyme Activation; Glutathione; Glycine; Intracellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Kinase 4; MAP Kinase Kinase Kinase 5; MAP Kinase Signaling System; Mesencephalon; Mice; Mice, Inbred C57BL; Molecular Chaperones; MPTP Poisoning; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Nuclear Proteins; Oncogene Proteins; Parkinsonian Disorders; Peroxiredoxins; Phosphorylation; Protein Deglycase DJ-1; Protein Processing, Post-Translational; Protein Transport; Substantia Nigra; Thioctic Acid

2007
An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin.
    Cell, 2001, Jun-29, Volume: 105, Issue:7

    Topics: Acetylcysteine; Brain; Cell Death; Cells, Cultured; Cysteine Proteinase Inhibitors; Endoplasmic Reticulum; Humans; Ligases; Microscopy, Fluorescence; Parkinsonian Disorders; Precipitin Tests; Protein Binding; Protein Folding; Receptors, Cell Surface; Recombinant Fusion Proteins; Two-Hybrid System Techniques; Ubiquitin-Conjugating Enzymes; Ubiquitin-Protein Ligases; Ubiquitins

2001
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine has a transient proliferative effect on PC12h cells and nerve growth factor additively promotes this effect: possible involvement of distinct mechanisms of activation of MAP kinase family proteins.
    Brain research. Developmental brain research, 2002, Feb-28, Volume: 133, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetylcysteine; Animals; Apoptosis; Brain; Cell Division; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Free Radical Scavengers; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 1; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Nerve Growth Factor; Neurons; p38 Mitogen-Activated Protein Kinases; Parkinsonian Disorders; PC12 Cells; Protein Serine-Threonine Kinases; Rats; Reactive Oxygen Species

2002